Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three treatments for stress urinary incontinence
2005-002323-14Phase 3Completed
- Sponsor
- Landspitali
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of duloxetine in stress urinary incontinence (SUI) (3 arms), sponsored by Landspitali. Primary endpoints: Treatment efficacy by electromyography, Quality of life assessment and 1 more. Started Aug 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on 2005-002323-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002323-14.